globenewswire.com · 21 jul

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AstraZeneca PLC- AZN

NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC (“AstraZeneca” or the “Company”) (NYSE: AZN).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

defenseworld.net · 21 jul

4,699 Shares in Astrazeneca Plc $AZN Purchased by Baader Bank Aktiengesellschaft

Baader Bank Aktiengesellschaft acquired a new position in Astrazeneca Plc (NYSE: AZN) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,699 shares of the company's stock, valued at approximately $920,000. Several other large investors have also modified

defenseworld.net · 21 jul

Andra AP fonden Makes New $46.60 Million Investment in Astrazeneca Plc $AZN

Andra AP fonden bought a new position in shares of Astrazeneca Plc (NYSE: AZN) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 236,302 shares of the company's stock, valued at approximately $46,603,000. Astrazeneca comprises 0.6% of Andra

zacks.com · 20 jul

Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know

Astrazeneca (AZN) closed the most recent trading day at $164.52, moving 2.59% from the previous trading session.

defenseworld.net · 20 jul

Astrazeneca Plc $AZN Shares Sold by Boston Common Asset Management LLC

Boston Common Asset Management LLC trimmed its position in shares of Astrazeneca Plc (NYSE: AZN) by 50.9% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 40,960 shares of the company's stock after selling 42,464 shares during the

defenseworld.net · 20 jul

Astrazeneca Plc $AZN Shares Acquired by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale boosted its holdings in Astrazeneca Plc (NYSE: AZN) by 4,529.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,783,927 shares of the company's stock after purchasing an additional 3,702,185 shares during the quarter. Astrazeneca comprises approximately 1.2% of

seekingalpha.com · 18 jul

AI Bubble Risks Make Dividend Stocks Attractive Again

I identify dividend stocks and REITs that could protect investors from AI bubble risks, geopolitics, and inflation while generating attractive income. My "ALLKA Dividend Rating" model separates quality dividend opportunities from yield traps by analyzing dividend sustainability, growth prospects, and valuation. The article explores three dividend strategies, "High-Yield Defensive," "Balanced Income," and "Pure Growth," designed for goals ranging from high yield to dividend growth.

247wallst.com · 17 jul

The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?

The FDA's approval of Merck (NYSE:MRK | MRK Price Prediction) enlicitide decanoate, marketed as Lipfendra, marks the first once-daily oral PCSK9 inhibitor cleared for adults with high LDL cholesterol, including heterozygous familial hypercholesterolemia.